Soleno Therapeutics (NASDAQ:SLNO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Soleno Therapeutics Stock (NASDAQ: SLNO) stock price, news, charts, stock research, profile.

Open	$46.82
Close	$44.82
Volume / Avg.	683.37K / 679.98K
Day Range	$44.66 - $47.09
52 Wk Range	35.70 - 60.92
Market Cap	$1.93B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	15.69%
Days to Cover	6.48

Recent News

PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker

NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$46.82
Close	$44.82
Volume / Avg.	683.37K / 679.98K
Day Range	$44.66 - $47.09
52 Wk Range	35.70 - 60.92
Market Cap	$1.93B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	15.69%
Days to Cover	6.48

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Soleno Therapeutics (SLNO) stock?

You can purchase shares of Soleno Therapeutics (NASDAQ:SLNO) through any online brokerage.

View our list of the best stock brokerages

Who are Soleno Therapeutics (SLNO) competitors?

Other companies in Soleno Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT), Xencor (NASDAQ:XNCR) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Soleno Therapeutics (SLNO) stock?

Soleno Therapeutics has a consensus price target of $69.86.

What is the current price for Soleno Therapeutics (SLNO)?

The stock price for Soleno Therapeutics (NASDAQ: SLNO) is $44.82 last updated December 27, 2024 at 4:00 PM EST.

Does Soleno Therapeutics (SLNO) pay a dividend?

There are no upcoming dividends for Soleno Therapeutics.

When is Soleno Therapeutics (NASDAQ:SLNO) reporting earnings?

Soleno Therapeutics’s Q4 earnings are confirmed for Wednesday, March 5, 2025.

Is Soleno Therapeutics (SLNO) going to split?

There is no upcoming split for Soleno Therapeutics.

What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Soleno Therapeutics

Soleno Therapeutics (SLNO) Forecast